1. Loss of HER2 Positivity after Trastuzumab in HER2-Positive Gastric Cancer: Is Change in HER2 Status Significantly Frequent?
   Yu Ishimine et al, 2015, Case Reports in Gastrointestinal Medicine CrossRef
2. A phase II study of modified docetaxel, cisplatin, and S-1 (mDCS) chemotherapy for unresectable advanced gastric cancer
   Naoki Uemura et al, 2017, Cancer Chemother Pharmacol CrossRef
3. Recent advances in photodynamic diagnosis of gastric cancer using 5-aminolevulinic acid
   Noriaki Koizumi, 2016, WJG CrossRef
4. The long-term survival of stage IV gastric cancer patients with conversion therapy
   Kazuya Yamaguchi et al, 2018, Gastric Cancer CrossRef
5. Conversion surgery after S-1 plus oxaliplatin combination chemotherapy for advanced gastric cancer with multiple liver metastases
   Tsutomu Namikawa et al, 2018, Clin J Gastroenterol CrossRef
6. Radical Gastrectomy After Chemotherapy May Prolong Survival in Stage IV Gastric Cancer: A Korean Multi-institutional Analysis
   Ho Seok Seo et al, 2018, World J Surg CrossRef
7. Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy
   Seung-Hoon Beom et al, 2018, BMC Cancer CrossRef
8. Conversion Surgery for Unresectable Advanced Gastric Cancer: A Systematic Review and Meta-Analysis
   Rui Du et al, 2019, Cancer Investigation CrossRef
9. Retrospective analysis of patients with advanced or metastatic gastric cancer in Colombia
   Diego Novick et al, 2019, Journal of Medical Economics CrossRef
10. The roles of surgical oncologists in the new era: minimally invasive surgery for early gastric cancer and adjuvant surgery for metastatic gastric cancer.
    Kazuhiro Yoshida et al, 2011, Pathobiology CrossRef
11. Preliminary trial of surgery after chemotherapy for advanced gastric cancer with peritoneal dissemination
    MANABU YAMAMOTO et al, 2012 CrossRef
12. Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer.
    Minoru Fukuchi et al, 2015, Ann. Surg. Oncol. CrossRef
13. Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer
    J. Kinoshita et al, 2015, European Journal of Surgical Oncology (EJSO) CrossRef
14. Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification.
    Kazuhiro Yoshida et al, 2016, Gastric Cancer CrossRef
15. Conversion therapy for gastric cancer: who can make conversion as successful as Goromaru?
    Masanori Terashima, 2016, Gastric Cancer CrossRef
16. Long-term survival and prognosis associated with conversion surgery in patients with metastatic gastric cancer
    Takahiro Einama et al, 2017 CrossRef
17. A case of advanced gastric cancer achieved a pathological complete response by chemotherapy
    Kazuhiro Tada et al, 2017, surg case rep CrossRef
18. Will molecular target agents enable the multidisciplinary treatment in stage IV gastric cancer?
    Kozo Kataoka et al, 2017, European Journal of Surgical Oncology (EJSO) CrossRef
19. Conversion Surgery for Stage IV Gastric Cancer
    Fei Zhang et al, 2019, Front. Oncol. CrossRef
20. Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis: a prospectively comparative study
    Ziyu Li et al, 2015, World J Surg Onc CrossRef
21. Clinical outcomes of radical gastrectomy following trastuzumab-based chemotherapy for stage IV HER2-positive gastric or gastroesophageal junction cancer
    Ryo Takahashi et al, 2020, Surg Today CrossRef
22. Advantages of ypTNM Staging in Post-surgical Prognosis for Initially Unresectable or Stage IV Gastric Cancers
    Gyu-Seong Jeong et al, 2020, J Gastric Cancer CrossRef
23. Current status of conversion surgery for stage IV gastric cancer
    Jun Kinoshita et al, 2021, Surg Today CrossRef
24. Conversion surgery for metastatic gastric cancer at 2 years after initial diagnosis of cancer of unknown primary with metastasis of cervical lymph nodes and ovary: a case report
    Masaki Suzuki et al, 2021, surg case rep CrossRef
25. International Retrospective Cohort Study of Conversion Therapy for Stage IV Gastric Cancer 1 (CONVO‐GC‐1)
    Kazuhiro Yoshida et al, 2021, Ann Gastroenterol Surg CrossRef
26. Conversion surgery for stage IV gastric cancer: a multicenter retrospective study
    Yosuke Kano et al, 2022, BMC Surg CrossRef
27. Exploratory Analysis of Patients With Gastric/Gastroesophageal Junction Adenocarcinoma With or Without Liver Metastasis From the Phase 3 RAINBOW Study
    Takatsugu Ogata et al, 2023, J Gastric Cancer CrossRef
28. Conversion surgery after successful response to chemotherapy (S-1 + oxaliplatin + nivolumab) in a patient with stage IV gastric cancer with peritoneal metastasis (P1, CY1): a case report
    Takayuki Noma et al, 2023, Int Canc Conf J CrossRef
29. Low Expectancy of Conversion Surgery with R0 Resection in Patients with CEA > 5.0 ng/mL at the Initial RECIST Evaluation for Metastatic Gastric Cancer
    Koki Nakanishi et al, 2023, Cancers CrossRef
30. Efficacy of conversion surgery on stage IV gastric cancer and its prognosis analysis
    Zhilong ZHAO et al, 2023, Panminerva Med CrossRef
31. Prognostic Factors of Survival in Patients With Gastric Cancer Under 45 Years Old Treated With Surgery in a Single Center in Mexico City
    Rafael Medrano Guzman et al, 2024 CrossRef